Healthcare & Life Sciences
Sirtris Pharmaceuticals
United States
acquiredacquired
acquired
Stage
2004
Founded
2
Investors
About
Sirtris Pharmaceuticals was a biopharmaceutical company focused on discovering and developing small molecule drugs to treat diseases of aging, including type 2 diabetes, cancer, and inflammatory diseases.
Explore Sirtris Pharmaceuticals's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.